当前蛋白身份:Q9GV45 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
5B0U Crystal structure of the mutated 19 kDa protein of Oplophorus luciferase (nanoKAZ) 提交 2015-11-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K,I90V, P115E, Q124K, Y138I, N166R 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.1 M di-ammonium tartrate
分辨率 1.71 Å R-free 0.226
5B0U Crystal structure of the mutated 19 kDa protein of Oplophorus luciferase (nanoKAZ) 提交 2015-11-04 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K,I90V, P115E, Q124K, Y138I, N166R 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.1 M di-ammonium tartrate
分辨率 1.71 Å R-free 0.226
5IBO 1.95A resolution structure of NanoLuc luciferase 提交 2016-02-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa) 片段:Full Length
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R DKA DECANOIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;20% (w/v) PEG 3350, 200 mM ammonium nitrate
分辨率 1.95 Å R-free 0.250
5IBO 1.95A resolution structure of NanoLuc luciferase 提交 2016-02-22 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa) 片段:Full Length
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R DKA DECANOIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;20% (w/v) PEG 3350, 200 mM ammonium nitrate
分辨率 1.95 Å R-free 0.250
7SNR 2.00A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R 非标准单体:是(mmCIF未提供具体位点) ACT ACETATE ION × 2 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;1.0 M ammonium citrate dibasic, 0.1 M sodium acetate trihydrate
分辨率 2.00 Å R-free 0.213
7SNR 2.00A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R 非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;1.0 M ammonium citrate dibasic, 0.1 M sodium acetate trihydrate
分辨率 2.00 Å R-free 0.213
7SNS 1.55A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R ACT ACETATE ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
分辨率 1.55 Å R-free 0.189
7SNS 1.55A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R ACT ACETATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
分辨率 1.55 Å R-free 0.189
7SNS 1.55A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R ACT ACETATE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
分辨率 1.55 Å R-free 0.189
7SNS 1.55A Resolution Structure of NanoLuc Luciferase 提交 2021-10-28 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R ACT ACETATE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
分辨率 1.55 Å R-free 0.189
7SNT 2.20A Resolution Structure of NanoLuc Luciferase with Bound Substrate Analog 3-methoxy-furimazine 提交 2021-10-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R 9Z5 (4S)-8-benzyl-2-[(furan-2-yl)methyl]-3-methoxy-6-phenylimidazo[1,2-a]pyrazine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.0 M sodium citrate dibasic, 0.1 M Tris, 0.2 M NaCl
分辨率 2.20 Å R-free 0.264
7SNT 2.20A Resolution Structure of NanoLuc Luciferase with Bound Substrate Analog 3-methoxy-furimazine 提交 2021-10-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.0 M sodium citrate dibasic, 0.1 M Tris, 0.2 M NaCl
分辨率 2.20 Å R-free 0.264
7SNW 1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576 提交 2021-10-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R MG MAGNESIUM ION × 1 SO4 SULFATE ION × 3 9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1 9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1 GOL GLYCEROL × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
分辨率 1.80 Å R-free 0.175
7SNW 1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576 提交 2021-10-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1 9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1 GOL GLYCEROL × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
分辨率 1.80 Å R-free 0.175
7SNW 1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576 提交 2021-10-28 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 28–196(169 aa)
突变:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1 9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
分辨率 1.80 Å R-free 0.175
7SNX 1.70A Resolution Structure of NanoBiT Complementation Reporter Complex of LgBit and SmBiT Subunits 提交 2021-10-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 28–183(156 aa) 片段:M-1 to S157
链 B 185–195(11 aa)
突变:;A4E, Q11E, G15A, Q18L, L27V, F31L, A33N, G35A, K43R, V44I, L46R, G51A, A54I, G67A, F68D, G71A, L72Q, M75E, I76V, I90V, H93P, I107L, D108N, P115E, Q124K, Y138I, N144T, L149M, G157S ; 突变:W161Y, C164F, N166E 非标准单体:是(mmCIF未提供具体位点) GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;1.5 M Na/K Phosphate, 4 (v/v) % 1,3-propanediol
分辨率 1.70 Å R-free 0.178
7SNY 2.10A Resolution Structure of NanoBiT Complementation Reporter Large Subunit LgBiT 提交 2021-10-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–183(156 aa) 片段:M-1 to S157
突变:;A4E, Q11E, G15A, Q18L, L27V, F31L, A33N, G35A, K43R, V44I, L46R, G51A, A54I, G67A, F68D, G71A, L72Q, M75E, I76V, I90V, H93P, I107L, D108N, P115E, Q124K, Y138I, N144T, L149M, G157S ; 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;15% (v/v) 2-methyl-2,4-pentanediol, 0.1 M sodium acetate, 2% (w/v) PEG 4000
分辨率 2.10 Å R-free 0.277
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
未记录 GOL GLYCEROL × 1 PG4 TETRAETHYLENE GLYCOL × 3 OXY OXYGEN MOLECULE × 1 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
未记录 PG4 TETRAETHYLENE GLYCOL × 1 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 28–196(169 aa)
未记录 PG4 TETRAETHYLENE GLYCOL × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 28–196(169 aa)
未记录 PG4 TETRAETHYLENE GLYCOL × 2 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 7 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 28–196(169 aa)
未记录 CL CHLORIDE ION × 4 NT0 N-(3-Benzyl-5-phenylpyrazin-2-yl)-2-(furan-2-yl)acetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQ6 NanoLuc luciferase with bound furimamide in surface allosteric site 提交 2022-08-11 Assembly 8 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 H 28–196(169 aa)
未记录 GOL GLYCEROL × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;200 mM MgCl2, 100 mM KCl, 25 mM Na acetate pH = 4.0, PEG 400
分辨率 1.69 Å R-free 0.183
8AQH NanoLuc-Y94A luciferase mutant 提交 2022-08-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
突变:Y94A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 2.80 Å R-free 0.305
8AQH NanoLuc-Y94A luciferase mutant 提交 2022-08-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
突变:Y94A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 2.80 Å R-free 0.305
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 28–196(169 aa)
未记录 CEI N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 28–196(169 aa)
未记录 CL CHLORIDE ION × 3 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 28–196(169 aa)
未记录 CL CHLORIDE ION × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 7 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 28–196(169 aa)
未记录 CEI N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8AQI NanoLuc luciferase with bound coelenteramide in surface allosteric site 提交 2022-08-12 Assembly 8 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 H 28–196(169 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
分辨率 1.99 Å R-free 0.207
8HCQ Cryo-EM structure of endothelin1-bound ETAR-Gq complex 提交 2022-11-02 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 27–184(158 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.01 Å
8HCX Cryo-EM structure of Endothelin1-bound ETBR-Gq complex 提交 2022-11-03 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 C 27–184(158 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.50 Å
8HNK CXCR3-DNGi complex activated by CXCL11 提交 2022-12-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 27–184(158 aa)
未记录 CLR CHOLESTEROL × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.01 Å
8HNL CXCR3-DNGi complex activated by PS372424 提交 2022-12-08 Assembly 1 信息不足 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 R 27–184(158 aa)
未记录 CLR CHOLESTEROL × 2 4AI (3S)-N-[(2S)-5-carbamimidamido-1-(cyclohexylmethylamino)-1-oxidanylidene-pentan-2-yl]-2-(4-oxidanylidene-4-phenyl-butanoyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.98 Å
8HNM CXCR3-DNGi complex activated by VUF11222 提交 2022-12-08 Assembly 1 信息不足 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 R 27–184(158 aa)
未记录 CLR CHOLESTEROL × 2 4IE [4-(2-bromophenyl)phenyl]methyl-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]-dimethyl-azanium × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.94 Å
8JPN Cryo-EM structure of succinate receptor bound to cis-epoxysuccinic acid coupling to Gi 提交 2023-06-12 Assembly 1 信息不足 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 R 28–184(157 aa)
未记录 U9S (2R,3S)-oxirane-2,3-dicarboxylic acid × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.90 Å
8K2X CXCR3-DNGi complex activated by CXCL10 提交 2023-07-14 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 27–184(158 aa)
未记录 CLR CHOLESTEROL × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.20 Å
9K07 Cryo-EM structure of the DSO-5a-bound human BRS3-Gq complex 提交 2024-10-15 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 28–183(156 aa)
未记录 A1EL6 [(1~{S})-1-[1,4-dimethoxy-8-nitroso-5-(oxidanylamino)naphthalen-2-yl]-2,2-dimethyl-but-3-enyl] furan-2-carboxylate × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.83 Å
9LWP Cryo-EM structure of the unliganded human BRS3-Gq complex 提交 2025-02-16 Assembly 1 信息不足 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 R 28–183(156 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.93 Å
9UPU Cryo-EM strucutre of CXCR4 complexed with agonist SDV1a 提交 2025-04-29 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 32–183(152 aa)
未记录 CLR CHOLESTEROL × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.80 Å
9UPV Cryo-EM structure of CXCR4 complexed with agonist SDVX1 提交 2025-04-29 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 32–183(152 aa)
未记录 CLR CHOLESTEROL × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.70 Å